Revvity | PKI - 债务



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 13.87B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


债务 更改 日
Agilent USD 3.35B 0 2025-12
Align Technology USD 114.45M 6.82M 2025-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Celltrion KRW 160.58B 733.3M 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 40M 40M 2025-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Illumina USD 2.55B 23M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 15.83B 109M 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Laboratory Of America USD 6.53B 3.9M 2025-12
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.15B 57.69M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
OraSure Technologies USD 782K 465K 2024-06
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pharma Mar EUR 47.54M 1.88M 2026-03
Qiagen NV USD 1.81B 314.82M 2025-12
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.83B 9.9M 2025-12
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Tilray USD 640.95M 35.17M 2022-06
Waters USD 1.49B 4.92M 2025-12
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03